PlantForm Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:PlantForm Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10635
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PlantForm Corp (PlantForm) is a biopharmaceutical company that develops and produces specialty antibody and protein drugs. The company’s pipeline products include biosimilar ranibizumab, trastuzumab, hD9 antibody for ricin exposure, recombinant butyrylcholinesterase, antibodies for HIV or AIDS and ebola virus. Its recombinant butyrylcholinesterase is an enzyme that provides prophylactic protection against nerve agents. PlantForm utilizes vivoxpress technology platform to produce biologic large molecule drugs including monoclonal antibodies and therapeutic proteins. It partners with other companies to develop additional targeted biosimilar and innovator drugs. The company operates through its offices located in Toronto and Sarnia in Canada; and California, the US. PlantForm is headquartered in Guelph, Ontario, Canada.

PlantForm Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PlantForm Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PlantForm Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PlantForm Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PlantForm Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
PlantForm Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PlantForm Corp, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
PlantForm Raises USD2 Million in Venture financing 10
Partnerships 11
PlantForm Forms Joint Venture with PharmaPraxis 11
Licensing Agreements 12
PlantForm Enters into Licensing Agreement with PharmaPraxis 12
PlantForm Enters Into Licensing Agreement With University of Guelph 13
Equity Offering 14
PlantForm Raises USD18.2 Million in Private Placement 14
PlantForm Corp – Key Competitors 15
PlantForm Corp – Key Employees 16
PlantForm Corp – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Joint Venture 17
Recent Developments 18
Product News 18
10/03/2017: PlantForm named 2017 DefenseTechConnect Innovation Award winner 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
PlantForm Corp, Pharmaceuticals & Healthcare, Key Facts 2
PlantForm Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PlantForm Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PlantForm Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PlantForm Corp, Deals By Therapy Area, 2012 to YTD 2018 8
PlantForm Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PlantForm Raises USD2 Million in Venture financing 10
PlantForm Forms Joint Venture with PharmaPraxis 11
PlantForm Enters into Licensing Agreement with PharmaPraxis 12
PlantForm Enters Into Licensing Agreement With University of Guelph 13
PlantForm Raises USD18.2 Million in Private Placement 14
PlantForm Corp, Key Competitors 15
PlantForm Corp, Key Employees 16
PlantForm Corp, Other Locations 17
PlantForm Corp, Joint Venture 17

List of Figures
PlantForm Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
PlantForm Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
PlantForm Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
PlantForm Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
PlantForm Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PlantForm Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
PlantForm Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PlantForm Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[PlantForm Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Madrigal Pharmaceuticals Inc (MDGL):製薬・医療:M&Aディール及び事業提携情報
    Summary Madrigal Pharmaceuticals Inc (Madrigal), formerly, Synta Pharmaceuticals Corp is a biopharmaceutical company focused on the development and commercialization of novel therapeutic candidates for the treatment of liver, cardiovascular and metabolic diseases. Its lead product candidate, MGL-319 …
  • EDF Energies Nouvelles SA:電力:M&Aディール及び事業提携情報
    Summary EDF Energies Nouvelles SA (EDF Energies Nouvelles) a subsidiary of Electricite de France S.A., develops, constructs, operates and maintains green electricity power plants in Europe and North America. The company produces electricity through various renewable energy sources such as wind, sola …
  • G Adventures Inc:企業の戦略・SWOT・財務情報
    G Adventures Inc - Strategy, SWOT and Corporate Finance Report Summary G Adventures Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Public Financial Holdings Ltd (626):企業の財務・戦略的SWOT分析
    Public Financial Holdings Ltd (626) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Shiseido Company, Limited:企業の戦略・SWOT・財務分析
    Shiseido Company, Limited - Strategy, SWOT and Corporate Finance Report Summary Shiseido Company, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • BrightSpring Health Services:企業の戦略的SWOT分析
    BrightSpring Health Services - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Edisun Power Europe AG (ESUN):電力:M&Aディール及び事業提携情報
    Summary Edisun Power Europe AG (Edisun Power) is a solar power producer. The company finances, develops and operates solar power plants in various European countries. It offers technical studies, legal and financial studies, custom design, installation, work monitoring, and operation and maintenance …
  • Active Biotech AB (ACTI):企業の財務・戦略的SWOT分析
    Active Biotech AB (ACTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • The Johnny Rockets Group, Inc.:企業の戦略・SWOT・財務情報
    The Johnny Rockets Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Johnny Rockets Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • NV Nederlandse Spoorwegen:企業の戦略・SWOT・財務情報
    NV Nederlandse Spoorwegen - Strategy, SWOT and Corporate Finance Report Summary NV Nederlandse Spoorwegen - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • UBS Wealth Management:企業の戦略・SWOT・財務情報
    UBS Wealth Management - Strategy, SWOT and Corporate Finance Report Summary UBS Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Strabag SE:企業の戦略・SWOT・財務情報
    Strabag SE - Strategy, SWOT and Corporate Finance Report Summary Strabag SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • TransAlta Corporation:発電所・企業SWOT分析
    TransAlta Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employe …
  • OGK-2 (OGKB):企業の財務・戦略的SWOT分析
    OGK-2 (OGKB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Vallourec SA:企業のM&A・事業提携・投資動向
    Vallourec SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Vallourec SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • American Rheinmetall Munitions, Inc.:企業の戦略・SWOT・財務情報
    American Rheinmetall Munitions, Inc. - Strategy, SWOT and Corporate Finance Report Summary American Rheinmetall Munitions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Haitong Securities Co., Ltd.:戦略・SWOT・企業財務分析
    Haitong Securities Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Haitong Securities Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Chiyoda Corp (6366):企業の財務・戦略的SWOT分析
    Chiyoda Corp (6366) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Luitpold Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Luitpold Pharmaceuticals Inc (Luitpold Pharmaceuticals), a subsidiary of Daiichi Sankyo Co Ltd is a manufacturer and marketer of drugs and medical devices. The company provides products such as injectable parenteral medications that are used in pharmacy admixtures and nutrient solutions, cri …
  • Canadian Natural Resources Ltd (CNQ):石油・ガス:M&Aディール及び事業提携情報
    Summary Canadian Natural Resources Ltd (Canadian Natural) is an independent upstream oil and gas company. The company carries out acquisition, exploration, development, production, marketing and sale of crude oil, natural gas and natural gas liquids (NGLs). Canadian Natural’s products include light …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆